Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
Int J Cardiol ; 319: 52-56, 2020 Nov 15.
Article in English | MEDLINE | ID: mdl-32470533

ABSTRACT

BACKGROUND: The long-term effect of tricuspid regurgitation (TR) after device implantation on long-term mortality remains unknown. In the present study, we sought to examine whether patients undergoing an implantable cardiac device procedure (pacemaker, cardiac defibrillator or cardiac resynchronisation therapy) have an increased risk of TR and to determine the effect of this on long-term survival. METHODS: A total of 304 patients who underwent device implant and had pre- and post-implant transthoracic echocardiogram were included in the analysis. All-cause mortality was the study endpoint over a follow-up period of median 11.6 years. RESULTS: New ≥ moderate tricuspid regurgitation post-device implantation developed in 66/304 (21.7%) patients. New right ventricular dysfunction post-device implantation occurred in 59/304 (19.4%) patients. Independent predictors of new RV dysfunction were ischaemic heart disease (OR 4.23, 95% CI 1.58 - 11.33, p = 0.004), left ventricular impairment (OR 2.74, 95% CI 5.41 - 30.00, p < 0.0001) and new ≥ moderate TR (OR 7.72, 95% CI 3.27 - 18.23, p < 0.001). Independent predictors of mortality were new ≥ moderate TR [HR: 3.14 (95% CI 1.29 - 7.63) p = 0.01] and new RV impairment [HR: 2.82 (95% CI 1.33 - 5.98) p = 0.01. CONCLUSIONS: Worsening TR and RV dysfunction post-device implantation is common. New post-implant ≥ moderate TR is associated with increased risk of new RV impairment and poor long term (>10 years) survival.


Subject(s)
Defibrillators, Implantable , Tricuspid Valve Insufficiency , Ventricular Dysfunction, Right , Defibrillators, Implantable/adverse effects , Follow-Up Studies , Humans , Retrospective Studies , Treatment Outcome , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve Insufficiency/surgery , Ventricular Dysfunction, Right/diagnostic imaging
2.
Heart ; 102(17): 1380-7, 2016 09 01.
Article in English | MEDLINE | ID: mdl-27056972

ABSTRACT

OBJECTIVES: High blood pressure (BP) is associated with diastolic dysfunction, but the consequence of elevated BP over the adult life course on diastolic function is unknown. We hypothesised that high BP in earlier adulthood would be associated with impaired diastolic function independent of current BP. METHODS: Participants in the Medical Research Council National Survey of Health and Development birth cohort (n=1653) underwent investigations including echocardiography at age 60-64 years. The relationships between adult BP, antihypertensive treatment (HTT) and echocardiographic measures of diastolic function were assessed using adjusted regression models. RESULTS: Increased systolic BP (SBP) at ages 36, 43 and 53 years was predictive of increased E/e' and increased left atrial volume. These effects were only partially explained by SBP at 60-64 years and increased left ventricular mass. HTT was also associated with poorer diastolic function after adjustment for SBP at 60-64 years. Faster rates of increase in SBP in midlife were also associated with increased poorer diastolic function. CONCLUSIONS: High SBP in midlife is associated with poorer diastolic function at age 60-64 years. Early identification of individuals with high BP or rapid rises in BP may be important for prevention of impaired cardiac function in later life.


Subject(s)
Blood Pressure , Hypertension/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Ventricular Dysfunction, Left/physiopathology , Ventricular Function, Left , Adult , Age Factors , Diastole , Echocardiography, Doppler , Female , Health Surveys , Humans , Hypertension/diagnosis , Hypertension/epidemiology , Hypertrophy, Left Ventricular/diagnostic imaging , Hypertrophy, Left Ventricular/epidemiology , Male , Middle Aged , Prognosis , Prospective Studies , Risk Assessment , Risk Factors , United Kingdom/epidemiology , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/epidemiology
3.
Eur Heart J ; 37(3): 256-63, 2016 Jan 14.
Article in English | MEDLINE | ID: mdl-26405233

ABSTRACT

AIMS: Clinical trials suggest that intracoronary delivery of autologous bone marrow-derived cells (BMCs) 1-7 days post-acute myocardial infarction (AMI) may improve left ventricular (LV) function. Earlier time points have not been evaluated. We sought to determine the effect of intracoronary autologous BMC on LV function when delivered within 24 h of successful reperfusion therapy. METHODS AND RESULTS: A multi-centre phase II randomized, double-blind, and placebo-controlled trial. One hundred patients with anterior AMI and significant regional wall motion abnormality were randomized to receive either intracoronary infusion of BMC or placebo (1:1) within 24 h of successful primary percutaneous intervention (PPCI). The primary endpoint was the change in left ventricular ejection fraction (LVEF) between baseline and 1 year as determined by advanced cardiac imaging. At 1 year, although LVEF increased compared with baseline in both groups, the between-group difference favouring BMC was small (2.2%; 95% confidence interval, CI: -0.5 to 5.0; P = 0.10). However, there was a significantly greater myocardial salvage index in the BMC-treated group compared with placebo (0.1%; 95% CI: 0.0-0.20; P = 0.048). Major adverse events were rare in both treatment groups. CONCLUSION: The early infusion of intracoronary BMC following PPCI for patients with AMI and regional wall motion abnormality leads to a small non-significant improvement in LVEF when compared with placebo; however, it may play an important role in infarct remodelling and myocardial salvage.


Subject(s)
Anterior Wall Myocardial Infarction/therapy , Bone Marrow Transplantation/methods , Anterior Wall Myocardial Infarction/pathology , Anterior Wall Myocardial Infarction/physiopathology , Computed Tomography Angiography , Double-Blind Method , Female , Humans , Magnetic Resonance Angiography , Male , Middle Aged , Natriuretic Peptide, Brain/metabolism , Peptide Fragments/metabolism , Percutaneous Coronary Intervention/methods , Quality of Life , Salvage Therapy/methods , Stroke Volume/physiology , Transplantation, Autologous , Ventricular Dysfunction, Left/diagnosis
4.
Appl Bionics Biomech ; 2015: 543492, 2015.
Article in English | MEDLINE | ID: mdl-27019586

ABSTRACT

Background. Common manufactured depth sensors generate depth images that humans normally obtain from their eyes and hands. Various designs converting spatial data into sound have been recently proposed, speculating on their applicability as sensory substitution devices (SSDs). Objective. We tested such a design as a travel aid in a navigation task. Methods. Our portable device (MeloSee) converted 2D array of a depth image into melody in real-time. Distance from the sensor was translated into sound intensity, stereo-modulated laterally, and the pitch represented verticality. Twenty-one blindfolded young adults navigated along four different paths during two sessions separated by one-week interval. In some instances, a dual task required them to recognize a temporal pattern applied through a tactile vibrator while they navigated. Results. Participants learnt how to use the system on both new paths and on those they had already navigated from. Based on travel time and errors, performance improved from one week to the next. The dual task was achieved successfully, slightly affecting but not preventing effective navigation. Conclusions. The use of Kinect-type sensors to implement SSDs is promising, but it is restricted to indoor use and it is inefficient on too short range.

5.
Eur Heart J ; 35(46): 3287-95, 2014 Dec 07.
Article in English | MEDLINE | ID: mdl-25246483

ABSTRACT

AIMS: Antecedent blood pressure (BP) may contribute to cardiovascular disease (CVD) independent of current BP. Blood pressure is associated with left ventricular mass index (LVMI) which independently predicts CVD. We investigated the relationship between midlife BP from age 36 to 64 and LVMI at 60-64 years. METHODS AND RESULTS: A total of 1653 participants in the British 1946 Birth Cohort underwent BP measurement and echocardiography aged 60-64. Blood pressure had previously been measured at 36, 43, and 53 years. We investigated associations between BP at each age and rate of change in systolic blood pressure (SBP) between 36-43, 43-53, and 53-60/64 years on LVMI at 60-64 years. Blood pressure from 36 years was positively associated with LVMI. Association with SBP at 53 years was independent of SBP at 60-64 years and other potential confounders (fully adjusted ß at 53 years = 0.19 g/m(2); 95% CI: 0.11, 0.27; P < 0.001). Faster rates of increase in SBP from 43 to 53 years and 53 to 60/64 years were associated with increased LVMI. Similar relationships were seen for diastolic, pulse, and mean pressure. Rate of increase in SBP between 43-53 years was associated with largest change in LVMI (ß at 43-53 years = 3.12 g/m(2); 95% CI: 1.53, 4.72; P < 0.001). People on antihypertensive medication (43 years onwards) had greater LVMI even after adjustment for current BP (ß at 43 years = 12.36 g/m(2); 95% CI: 3.19, 21.53; P = 0.008). CONCLUSION: Higher BP in midlife and rapid rise of SBP in 5th decade is associated with higher LVMI in later life, independent of current BP. People with treated hypertension have higher LVMI than untreated individuals, even accounting for their higher BP. Our findings emphasize importance of midlife BP as risk factor for future CVD.


Subject(s)
Blood Pressure/physiology , Hypertension/complications , Hypertrophy, Left Ventricular/etiology , Ventricular Remodeling/physiology , Adult , Age Factors , Antihypertensive Agents/therapeutic use , Female , Humans , Hypertension/drug therapy , Hypertension/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Male , Middle Aged , Prospective Studies , Risk Factors
6.
Clin Sci (Lond) ; 124(6): 391-401, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22988837

ABSTRACT

Myocardial function is depressed in sepsis and is an important prognosticator in the human condition. Using echocardiography in a long-term fluid-resuscitated Wistar rat model of faecal peritonitis we investigated whether depressed myocardial function could be detected at an early stage of sepsis and, if so, whether the degree of depression could predict eventual outcome. At 6 h post-insult, a stroke volume <0.17 ml prognosticated 3-day mortality with positive and negative predictive values of 93 and 80%, respectively. Subsequent fluid loading studies demonstrated intrinsic myocardial depression with poor-prognosis animals tolerating less fluid than either good-prognosis or sham-operated animals. Cardiac gene expression analysis at 6 h detected 527 transcripts significantly up- or down-regulated by the septic process, including genes related to inflammatory and cell cycle pathways. Predicted mortality was associated with significant differences in transcripts of genes expressing proteins related to the TLR2/MyD88 (Toll-like receptor 2/myeloid differentiation factor 88) and JAK/STAT (Janus kinase/signal transducer and activator of transcription) inflammatory pathways, ß-adrenergic signalling and intracellular calcium cycling. Our findings highlight the presence of myocardial depression in early sepsis and its prognostic significance. Transcriptomic analysis in heart tissue identified changes in signalling pathways that correlated with clinical dysfunction. These pathways merit further study to both better understand and potentially modify the disease process.


Subject(s)
Myocardium/metabolism , Sepsis/physiopathology , Transcriptome , Animals , Janus Kinases/biosynthesis , Male , Models, Animal , Myeloid Differentiation Factor 88/biosynthesis , Peritonitis/physiopathology , Prognosis , Rats , STAT Transcription Factors/biosynthesis , Signal Transduction/physiology , Toll-Like Receptor 2/biosynthesis
7.
Eur Heart J Cardiovasc Imaging ; 13(10): 819-26, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22634740

ABSTRACT

AIMS: Haemodynamics alone do not fully explain symptoms and prognosis in clinically severe aortic stenosis (AS). Myocardial disease, specifically diffuse myocardial fibrosis (DMF), may contribute. We used equilibrium contrast cardiovascular magnetic resonance (EQ-CMR) and sought to non-invasively measure DMF in severe AS and determine its clinical significance before and after valve replacement. METHODS AND RESULTS: Patients with severe AS underwent echocardiography, brain natriuretic peptide (BNP), 6 min walk test (6MWT), and EQ-CMR pre- (n = 63) at baseline and at 6 months post- (n = 42) aortic valve replacement (AVR). EQ-CMR was also performed in 30 normal controls. Baseline: patients with AS had more DMF than controls (18 vs. 13%, P = 0.007) with a wide range (5-38%) that overlapped controls. The extent of diffuse fibrosis correlated inversely with the 6MWT performance (r(2) = 0.22, P = 0.001). Those with severe diastolic dysfunction had more DMF (P = 0.01). On multivariable analysis, the predictors of performance at 6MWT were diffuse fibrosis and BNP (P = 0.003 and 0.02, respectively). Post-op: following valve replacement, morphological and functional parameters improved [6 MWT, LA area, BNP, left ventricular (LV) hypertrophy, and volumes]. LV hypertrophy regression was shown to be cell volume reduction (P < 0.001) and not fibrosis regression (P = 0.54). Of the five deaths over six-month follow-up, four occurred in patients in the highest tertile of DMF. CONCLUSION: DMF as measured by EQ-CMR is elevated in severe AS vs. normal controls but with a considerable overlap. It correlates with functional capacity at baseline. LV hypertrophy regression 6 months after AVR is cellular rather than fibrosis resolution.


Subject(s)
Aortic Valve Stenosis/diagnosis , Contrast Media , Endomyocardial Fibrosis/diagnosis , Magnetic Resonance Imaging, Cine , Aged , Aortic Valve Stenosis/pathology , Aortic Valve Stenosis/surgery , Disease Progression , Endomyocardial Fibrosis/pathology , Endomyocardial Fibrosis/surgery , Exercise Test , Exercise Tolerance , Female , Hemodynamics , Humans , Hypertrophy, Left Ventricular , Male , Middle Aged , Prognosis , Prospective Studies , Severity of Illness Index , Statistics as Topic
9.
Arch Cardiovasc Dis ; 103(8-9): 447-53, 2010.
Article in English | MEDLINE | ID: mdl-21074123

ABSTRACT

BACKGROUND: Tako-Tsubo cardiomyopathy is a clinical entity mimicking acute coronary syndrome. Assessment of left ventricular function may be difficult using conventional echocardiography. AIMS: to characterize left ventricular systolic function using contrast echocardiography in Tako-Tsubo cardiomyopathy. METHODS: We prospectively studied 63 consecutive women admitted for suspected acute coronary syndrome who underwent coronary arteriography, biplane left ventricular angiography and conventional and contrast echocardiography; 25 women had Tako-Tsubo cardiomyopathy (group 1), 25 women had proven coronary artery disease (group 2) and 13 women had no significant coronary lesion (group 3). Echocardiographic interpretation was performed by two observers: a physician trainee (observer 1) and an experienced investigator (observer 2). RESULTS: Left ventricular segments were assessed for wall motion abnormalities, which were present in 70 and 88% (observer 1) and in 91 and 99% (observer 2), using conventional and contrast echocardiography, respectively (P<0.0001). Accuracy for the diagnosis of Tako-Tsubo cardiomyopathy was improved significantly for both observers using contrast echocardiography: for observer 1, sensitivity was 56 and 88%, respectively, using conventional and contrast echocardiography (P=0.01), whereas for observer 2, sensitivity was 72 and 96%, respectively (P=0.04). Interobserver agreement was excellent using contrast agent (kappa=0.85 vs 0.34 using conventional echocardiography). The blinded review of left ventriculograms distinguished Tako-Tsubo cardiomyopathy from coronary artery disease correctly in 96% of cases. CONCLUSIONS: Contrast echocardiography could be used in routine practice to replace left ventricular angiography in Tako-Tsubo cardiomyopathy.


Subject(s)
Contrast Media , Echocardiography , Phospholipids , Sulfur Hexafluoride , Takotsubo Cardiomyopathy/diagnostic imaging , Ventricular Function, Left , Aged , Aged, 80 and over , Chi-Square Distribution , Coronary Angiography , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/physiopathology , Coronary Circulation , Female , Humans , Middle Aged , Myocardial Perfusion Imaging , Observer Variation , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Systole , Takotsubo Cardiomyopathy/physiopathology
10.
Circ Cardiovasc Genet ; 3(6): 513-22, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20937667

ABSTRACT

BACKGROUND: (6R)-5,6,7,8-Tetrahydro-l-biopterin (BH4) is a cofactor for enzymes involved in catecholamine and nitric oxide generation whose synthesis is initiated by GTP cyclohydrolase I (GTPCH-1), encoded by GCH1. In the absence of a potent, specific GTPCH-1 inhibitor, natural BH4 deficiency caused by mutations in GCH1 in the rare movement disorder, DOPA-responsive dystonia (OMIM DYT5), offers the opportunity to study the role of endogenous BH4 in humans. METHODS AND RESULTS: In 16 DOPA-responsive dystonia patients with mutations predicted to affect GTPCH-1 expression or function and in age- and sex-matched control subjects, we measured plasma biopterin and nitrogen oxides by high-performance liquid chromatography and the Griess reaction, respectively, endothelial function by brachial artery flow-mediated dilation (FMD), sympathetic function by measurement of plasma norepinephrine, epinephrine, and heart rate and blood pressure in response. Cardiac function and structure were assessed by echocardiography. Plasma biopterin was lower in patients (5.76±0.53 versus 8.43±0.85 nmol/L, P=0.03), but plasma NO(2)(-)/NO(3)(-) (NOx) (median, 9.06 [interquartile range, 5.35 to 11.04] versus 8.40 [interquartile range, 5.28 to 11.44] µmol/L, P=1) and FMD were not lower (7.7±0.8% versus 7.9±0.9%, P=0.91). In patients but not control subjects, FMD was insensitive to nitric oxide synthase inhibition (FMD at baseline, 6.7±2.1%; FMD during l-NMMA infusion, 6.2±2.5, P=0.68). The heart rate at rest was higher in patients, but the heart rate and blood pressure response to sympathetic stimulation did not differ in patients and control subjects despite lower concentrations of norepinepherine (264±8 pg/mL versus 226±9 pg/mL, P=0.006) and epinephrine (33.8±5.2 pg/mL versus 17.8±4.6 pg/mL, P=0.03) in patients. There was also no difference in cardiac function and structure. CONCLUSIONS: Sympathetic, cardiac, and endothelial functions are preserved in patients with GCH1 mutations despite a neurological phenotype, reduced plasma biopterin, and norepinepherine and epinephrine concentrations. Lifelong endogenous BH4 deficiency may elicit developmental adaptation through mechanisms that are inaccessible during acquired BH4 deficiency in adulthood.


Subject(s)
Biopterins/analogs & derivatives , GTP Cyclohydrolase/genetics , Mutation , Adaptation, Physiological , Adolescent , Age of Onset , Biopterins/blood , Biopterins/deficiency , Case-Control Studies , Child , Child, Preschool , Dystonic Disorders/etiology , Endothelium, Vascular , Epinephrine/blood , GTP Cyclohydrolase/metabolism , Heart Function Tests , Humans , Nitrogen Oxides/blood , Norepinephrine/blood , Sympathetic Nervous System/physiology
11.
Am J Cardiol ; 105(4): 527-31, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-20152249

ABSTRACT

The aim of this study was to evaluate the prognostic value of tissue Doppler imaging (TDI) in carcinoid heart disease (CHD). We prospectively enrolled 56 consecutive patients with proved digestive endocrine tumor and carcinoid syndrome. All patients underwent serial conventional, contrast, and TDI echocardiographic studies. The end point was all-cause mortality. Mean follow-up was 34 +/- 21 months. At the end of follow-up, 30 patients (54%) presented right CHD and 13 patients (23%) left CHD. A progression of CHD was documented in 23 patients (41%). Twenty-two patients (39%) died during follow-up. According to mortality receiver operating characteristic curves, ratio of early transmitral flow velocity to early diastolic mitral annulus velocity (E/e' ratio) associated with an optimal sensitivity of 80% and specificity of 90% was 8. Mortality rate was significantly higher when the E/e' ratio was >or=8 (94% vs 10% when E/e' ratio was <8, p <0.0001). Using univariate analysis, the following factors were associated with death: left-sided CHD (p = 0.07) and E/e' ratio >or=8 (p <0.0001). The only independent marker of death detected by multivariate analysis was an E/e' ratio >or=8 (odds ratio 6.2, 95% confidence interval 1.95 to 19.7, p = 0.002). In conclusion, TDI used during routine transthoracic echocardiography can be helpful to identify high-risk patients with CHD.


Subject(s)
Carcinoid Heart Disease/diagnostic imaging , Echocardiography, Doppler , Malignant Carcinoid Syndrome/diagnostic imaging , Adult , Aged , Aged, 80 and over , Analysis of Variance , Carcinoid Heart Disease/mortality , Disease Progression , Female , Follow-Up Studies , France/epidemiology , Humans , Male , Malignant Carcinoid Syndrome/mortality , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Prognosis , Prospective Studies , Risk Assessment , Sensitivity and Specificity , Survival Rate
12.
Vasc Health Risk Manag ; 5(1): 1-7, 2009.
Article in English | MEDLINE | ID: mdl-19436664

ABSTRACT

Cardiovascular disease is the leading cause of death in patients with diabetes therefore prompt diagnosis and treatment of high risk groups is essential. Dobutamine stress echocardiography is a safe, cheap and reliable method for coronary artery disease diagnosis and provides important long term prognostic information. The diagnostic accuracy and prognostic power of this technique has been validated by a number of studies on patients with and without diabetes. This article discusses the application, interpretation, and accuracy of stress echocardiography both in the general population and in patients with diabetes. The role of advanced imaging modalites such as myocardial contrast agents and tissue Doppler imaging is also explored.


Subject(s)
Diabetes Complications/diagnostic imaging , Echocardiography, Stress , Myocardial Ischemia/diagnostic imaging , Contrast Media , Coronary Circulation , Diabetes Complications/physiopathology , Dobutamine , Echocardiography, Doppler , Echocardiography, Stress/methods , Humans , Image Interpretation, Computer-Assisted , Myocardial Ischemia/physiopathology , Predictive Value of Tests , Reproducibility of Results , Risk Assessment , Vasodilator Agents
13.
Coron Artery Dis ; 20(3): 230-7, 2009 May.
Article in English | MEDLINE | ID: mdl-19387250

ABSTRACT

OBJECTIVE: To determine whether a quantitative measurement of peak systolic velocity (PSV) during dobutamine stress echocardiography (DSE) detects severe coronary artery disease (CAD) and predicts mortality in patients with end-stage renal disease. METHODS: One hundred and forty renal transplant candidates had DSE and coronary angiography. DSE analysis was performed using conventional visual wall motion assessment, longitudinal PSV, and combining the two modalities. Failure of PSV to rise by more than 50% predicted an ischemic response. Significant CAD was defined as luminal stenosis greater than 70%. RESULTS: The number of positive DSE studies according to conventional, PSV, and combined criteria was 41 (30%), 42 (31%), and 46 (34%) respectively. Forty patients (29%) had significant CAD at angiography. The sensitivity, specificity, positive and negative predictive values for conventional DSE analysis were 84, 91, 86, and 90% respectively. The same values for PSV analysis were 86, 92, 86, and 91%, respectively. The same values for the combination of visual and PSV analysis were 88, 94, 87, and 92% respectively. The differences between the three methods were not statistically significant. Sensitivity for single-vessel CAD (P=0.05) and circumflex artery disease (P=0.05) diagnosis was higher with PSV compared with conventional DSE analysis. Failure of PSV to rise by more than 50% during DSE was associated with significantly increased mortality (P=0.001). CONCLUSION: A quantitative interpretation of DSE, based on the percentage rise of PSV during stress, accurately detects CAD and predicts prognosis in end-stage renal disease.


Subject(s)
Coronary Stenosis/diagnostic imaging , Echocardiography, Doppler , Echocardiography, Stress , Kidney Failure, Chronic/diagnostic imaging , Adult , Aged , Coronary Angiography , Coronary Stenosis/mortality , Coronary Stenosis/physiopathology , Female , Humans , Kaplan-Meier Estimate , Kidney Failure, Chronic/mortality , Kidney Failure, Chronic/physiopathology , Male , Middle Aged , Myocardial Contraction , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Prospective Studies , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index , Time Factors , Ventricular Dysfunction, Left/diagnostic imaging
14.
Ultrasound Med Biol ; 34(6): 885-91, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18295391

ABSTRACT

Renal transplant recipients (RTRs) have a high incidence of erectile dysfunction (ED). Differentiation of penile vasculogenic impotence from other causes is important for treatment. Conventional 2-D color Doppler assessment after intracavernosal stimulant injection often fails to produce reliable results because of limited views by the cross-sectional imaging and the painful procedure. In comparison to the findings in three healthy volunteers, we determined cavernosal vascular hemodynamics in eight RTRs with ED before and after oral sildenafil by using live 3-D ultrasound and dynamic 3-D color Doppler. Results showed that, before sildenafil, penile arterial flow signals could only be reliably detected in one patient. After sildenafil, all had reliably detectable flow with grades II to III erection. Our data suggest that 3-D volumetric changes of the penis and its vasculature during erection can be studied by this technique and that this method could be useful for the evaluation of new drugs and therapeutic biofeedback.


Subject(s)
Erectile Dysfunction/diagnostic imaging , Imaging, Three-Dimensional , Kidney Transplantation , Piperazines/therapeutic use , Sulfones/therapeutic use , Ultrasonography, Doppler, Color/methods , Vasodilator Agents/therapeutic use , Administration, Oral , Adult , Blood Flow Velocity , Erectile Dysfunction/drug therapy , Erectile Dysfunction/physiopathology , Feasibility Studies , Humans , Impotence, Vasculogenic/complications , Impotence, Vasculogenic/diagnostic imaging , Male , Middle Aged , Penis/blood supply , Penis/diagnostic imaging , Purines/therapeutic use , Sildenafil Citrate , Treatment Outcome
15.
Eur Heart J ; 28(15): 1886-93, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17595193

ABSTRACT

AIMS: To investigate the early clinical and physiological consequences of relieving chronic right ventricular (RV) volume overload with percutaneous pulmonary valve implantation (PPVI). METHODS AND RESULTS: We selected 17 patients (age 21.2 +/- 8.7 years), from a total of 125 who underwent PPVI, because they had important pulmonary regurgitation (PR) [regurgitant fraction > 25% on magnetic resonance (MR)] and an echocardiographic gradient < 50 mmHg across the RV outflow tract. Cardiopulmonary exercise testing, tissue Doppler and MR were performed before and within 3 months of PPVI. Following PPVI, PR (40.7 +/- 7.3 to 4.1 +/- 6.1%, P < 0.001) and RV end-diastolic volume fell (115.4 +/- 33.1 to 98.9 +/- 32.0 mL/m(2), P = 0.001); effective RV stroke volume increased (34.3 +/- 7.8 to 44.4 +/- 9.3 mL/m(2), P < 0.001). Left ventricular end-diastolic volume (66.6 +/- 18.0 to 73.4 +/- 16.5 mL/m(2), P = 0.014), stroke volume (38.4 +/- 11.1 to 46.4 +/- 10.2 mL/m(2), P = 0.001) and ejection fraction (57.8 +/- 8.1 to 63.5 +/- 5.2 mL/m(2), P = 0.001) increased. Pulmonary artery diastolic pressure (8.9 +/- 4.5 to 12.5 +/- 5.2 mmHg, P = 0.041) and mitral E/Ea increased (from 9.0 +/- 2.0 to 11.6 +/- 3.1, P = 0.003). Patients felt better, but standard measures of exercise capacity were unchanged. CONCLUSION: PPVI relieves PR and restores compensatory cardiac performance. The lack of improvement in exercise parameters suggests that, in contrast to pressure overload, the contractile reserve of chronically volume-overloaded myocardium is limited.


Subject(s)
Heart Valve Prosthesis , Heart Ventricles/pathology , Pressure , Pulmonary Valve Insufficiency/pathology , Pulmonary Valve/pathology , Adolescent , Adult , Child , Chronic Disease , Exercise Test , Exercise Tolerance , Female , Heart Ventricles/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Pulmonary Valve/diagnostic imaging , Pulmonary Valve Insufficiency/diagnostic imaging , Ultrasonography , Ventricular Function
16.
Curr Opin Investig Drugs ; 8(3): 232-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17408119

ABSTRACT

The outcome of acute coronary syndromes is usually poor in patients with end-stage renal disease (ESRD), and the early detection of myocardial ischemia is therefore essential in this group. However, the diagnosis of ischemina is often problematic in patients with ESRD, as cardiac symptoms and electrocardiography are not reliable predictors in this context. Silent ischemia is common and resting ECG is often abnormal in patients with ESRD. Therefore, alternatives to these predictors have been sought, and this review explores the role of myocardial perfusion imaging, dobutamine stress echocardiography and biochemical markers for use in the diagnosis of ischemia and risk stratification in patients with ESRD.


Subject(s)
Kidney Failure, Chronic/complications , Myocardial Ischemia/diagnosis , Biomarkers/blood , Echocardiography, Stress/methods , Humans , Myocardial Ischemia/complications , Myocardial Ischemia/physiopathology , Radionuclide Imaging/methods
17.
Clin Sci (Lond) ; 113(1): 25-32, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17284166

ABSTRACT

The early diagnosis of myocardial ischaemia is problematic in patients with ESRD (end-stage renal disease). The aim of the present study was to determine whether IMA (ischaemia-modified albumin) increases during dobutamine stress and detects myocardial ischaemia in patients with ESRD. A total of 114 renal transplant candidates were studied prospectively, and all received DSE (dobutamine stress echocardiography). IMA levels were taken at baseline and 1 h after cessation of DSE. A total of 35 patients (31%) had a positive DSE result. Baseline IMA levels were not significantly different in the DSE-positive and -negative groups. The increase in IMA was significantly higher in the DSE-positive group compared with those with no ischaemic response (26.5 +/- 19.1 compared with 8.2 +/- 9.6 kU/l respectively; P = 0.007; where kU is kilo-units). From ROC (receiver operator charactertistic) curve analysis, the optimal IMA increase to predict an ischaemic response was 20 kU/l, with a sensitivity of 81% and a specificity of 72% [area under the curve, 0.80 (95% confidence interval, 0.44-0.94); P = 0.03]. There were 18 deaths, ten of which were cardiac in nature over a follow up period of 2.25 +/- 0.71 years. An increase in IMA > or = 20 kU/l was associated with significantly worse survival (P = 0.02). In conclusion, IMA is a moderately accurate marker of myocardial ischaemia in ESRD. Patients with an increase in IMA > or = 20 kU/l during DSE had significantly worse survival.


Subject(s)
Kidney Failure, Chronic/complications , Myocardial Ischemia/diagnosis , Serum Albumin/metabolism , Adult , Aged , Biomarkers/metabolism , Echocardiography, Stress , Female , Humans , Kidney Failure, Chronic/mortality , Kidney Failure, Chronic/surgery , Kidney Transplantation , Male , Middle Aged , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/mortality , Prospective Studies
18.
Atherosclerosis ; 191(2): 348-54, 2007 Apr.
Article in English | MEDLINE | ID: mdl-16647710

ABSTRACT

BACKGROUND: We sought to determine whether mitral annular calcification (MAC) predicts mortality and cardiac disease in a group of renal transplant candidates. METHODS: Hundred and forty patients were prospectively studied. All had echocardiography and coronary angiography. Significant coronary artery disease (CAD) was defined as luminal stenosis >70% by visual estimation in at least one coronary artery. RESULTS: There were 21 deaths over a follow-up period of 2.2+/-0.7 years. MAC occurred in 56 patients (40%) and was associated with higher mortality (p=0.04). Patients with MAC were older (p=or<0.001), had larger left ventricular (LV) end systolic (p=0.005) and LV end diastolic (p=0.04) diameter, larger left atrial diameter (p=0.001), lower LV fractional shortening (p=0.003), larger LV mass index (p=0.04) and higher mitral E/Ea ratio (p=0.03) compared to those without. Plasma calcium (p=0.002), phosphate (p=0.004), cardiac troponin T (p=0.03), N-terminal Pro-B-type natriuretic peptide (p=0.004) concentrations were higher in those with MAC but gender, total cholesterol, haemoglobin and creatinine were similar in the two groups. The proportion diabetic (p=0.03), on dialysis (p=0.05), with significant CAD (p=or<0.001), taking calcium containing phosphate binders (p=0.02) and Vitamin D3 (p=0.04) was significantly higher in those with MAC. Significant CAD (OR 12, 95% CI 3.25, p=0.001) was the only independent associate of MAC. CONCLUSIONS: MAC is associated with increased mortality and significant CAD in ESRD. These patients have increased LV cavity size, poorer LV systolic function, higher LV filling pressures compared to patients without MAC.


Subject(s)
Calcinosis/complications , Coronary Artery Disease/diagnosis , Coronary Artery Disease/etiology , Heart Valve Diseases/complications , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/mortality , Mitral Valve/pathology , Adult , Calcinosis/etiology , Calcinosis/mortality , Calcinosis/pathology , Coronary Angiography , Coronary Artery Disease/mortality , Coronary Artery Disease/pathology , Echocardiography , Female , Follow-Up Studies , Heart Valve Diseases/etiology , Heart Valve Diseases/mortality , Heart Valve Diseases/pathology , Heart Ventricles/pathology , Humans , Kaplan-Meier Estimate , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/physiopathology , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Severity of Illness Index , Time Factors , United Kingdom/epidemiology , Ventricular Function, Left
19.
Heart ; 93(4): 464-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-16980518

ABSTRACT

BACKGROUND: Given the high cardiac mortality of renal transplant recipients, identification of high-risk patients is important to offer appropriate treatment before transplantation. AIM: To determine patients with high mortality after renal transplantation despite selection according to current criteria. METHODS: Preoperative parameters were collected from 203 renal transplant recipients over a follow-up time of 3.6 (1.9) years. The primary end point was all-cause mortality. RESULTS: 22 deaths (11%) and 12 cardiac failures (6%) were observed. Non-survivors were older (p< or =0.001), had larger left ventricular end-systolic diameter (LVSD) (p< or =0.001) and end-diastolic diameter (p = 0.002), and lower ejection fraction (p< or =0.001). Left ventricular mass index (p = 0.001), maximal wall thickness (p = 0.006) and the proportion with mitral annular calcification (p = 0.001) were significantly higher in the non-survivors. The risk factors for ischaemic heart disease and exercise test data were not significantly different between the two groups. Four independent predictors of mortality after renal transplantation were identified: age > or =50 years (p = 0.002), LVESD > or =3.5 cm (p = 0.002), maximal wall thickness > or =1.4 cm (p = 0.014) and mitral annular calcification (p = 0.036). The 5-year survival estimates for 0, 1, 2 and 3 prognostic factors were 96%, 86%, 69% and 38%, respectively. No patient had four prognostic factors. In patients > or =50 years, the 5-year survival estimates for 0, 1 and 2 additional prognostic factors were 73%, 45% and 18%, respectively. CONCLUSION: In addition to selection according to current guidelines, age and three conventional echocardiography parameters may further improve risk stratification before renal transplantation.


Subject(s)
Coronary Artery Disease/mortality , Kidney Failure, Chronic/surgery , Kidney Transplantation/mortality , Adult , Aged , Coronary Artery Disease/complications , Coronary Artery Disease/diagnostic imaging , Echocardiography/standards , Female , Heart Failure/etiology , Heart Failure/mortality , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/mortality , Kidney Transplantation/diagnostic imaging , Male , Middle Aged , Observer Variation , Patient Selection , Peripheral Vascular Diseases/complications , Peripheral Vascular Diseases/diagnosis , Predictive Value of Tests , Prospective Studies , Risk Assessment , Treatment Outcome
20.
Circulation ; 113(17): 2037-44, 2006 May 02.
Article in English | MEDLINE | ID: mdl-16636174

ABSTRACT

BACKGROUND: Right ventricular outflow tract obstruction (RVOTO) is a common problem after repair of congenital heart disease. Percutaneous pulmonary valve implantation (PPVI) can treat this condition without consequent pulmonary regurgitation or cardiopulmonary bypass. Our aim was to investigate the clinical and physiological response to relieving RVOTO. METHODS AND RESULTS: We studied 18 patients who underwent PPVI for RVOTO (72% male, median age 20 years) from a total of 93 who had this procedure for various indications. All had a right ventricular outflow tract (RVOT) gradient >50 mm Hg on echocardiography without important pulmonary regurgitation (less than mild or regurgitant fraction <10% on magnetic resonance imaging [MRI]). Cardiopulmonary exercise testing, tissue Doppler echocardiography, and MRI were performed before and within 50 days of PPVI. PPVI reduced RVOT gradient (51.4 to 21.7 mm Hg, P<0.001) and right ventricular systolic pressure (72.8 to 47.3 mm Hg, P<0.001) at catheterization. Symptoms and aerobic (25.7 to 28.9 mL.kg(-1).min(-1), P=0.002) and anaerobic (14.4 to 16.2 mL.kg(-1).min(-1), P=0.002) exercise capacity improved. Myocardial systolic velocity improved acutely (tricuspid 4.8 to 5.3 cm/s, P=0.05; mitral 4.7 to 5.5 cm/s, P=0.01), whereas isovolumic acceleration was unchanged. The tricuspid annular velocity was not maintained on intermediate follow-up. Right ventricular end-diastolic volume (99.9 to 89.7 mL/m2, P<0.001) fell, whereas effective stroke volume (43.7 to 48.3 mL/m2, P=0.06) and ejection fraction (48.0% to 56.8%, P=0.01) increased. Left ventricular end-diastolic volume (72.5 to 77.4 mL/m2, P=0.145), stroke volume (45.3 to 50.6 mL/m2, P=0.02), and ejection fraction (62.6% to 65.8%, P=0.03) increased. CONCLUSIONS: PPVI relieves RVOTO, which leads to an early improvement in biventricular performance. Furthermore, it reduces symptoms and improves exercise tolerance. These findings have important implications for the management of this increasingly common condition.


Subject(s)
Heart Defects, Congenital/surgery , Heart Valve Prosthesis Implantation/methods , Pulmonary Valve/surgery , Ventricular Outflow Obstruction/surgery , Adolescent , Adult , Blood Pressure , Child , Echocardiography, Doppler , Exercise Test , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Stents , Ventricular Function, Left
SELECTION OF CITATIONS
SEARCH DETAIL
...